Clinical Trials Logo

Essential Hypertension clinical trials

View clinical trials related to Essential Hypertension.

Filter by:

NCT ID: NCT01083017 Completed - Hypertension Clinical Trials

Resistant Arterial Hypertension Cohort Study

RAHyCo
Start date: April 2011
Phase:
Study type: Observational

The purpose of this study is to investigate the epidemiology of resistant hypertension, evaluate the efficacy and feasibility of a standardized drug treatment regimen (including the randomization of two doses of the diuretic used - chlorthalidone), study two interventions in the group of patients that is non-compliant, and study environmental and genetic variables of individuals with resistant hypertension in a family design.

NCT ID: NCT01042392 Completed - Clinical trials for Essential Hypertension

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients

ALIAS
Start date: November 2009
Phase: Phase 4
Study type: Interventional

This prospective multicenter, double blind study will evaluate the efficacy and safety of aliskiren versus ramipril in patients with moderate systolic essential hypertension.

NCT ID: NCT01033071 Completed - Clinical trials for Essential Hypertension

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Start date: January 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the antihypertensive effect of azilsartan medoxomil plus chlorthalidone, once daily (QD), to olmesartan medoxomil plus hydrochlorothiazide in participants with moderate to severe hypertension.

NCT ID: NCT01022515 Completed - Clinical trials for Essential Hypertension

Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma

PHEO
Start date: November 2008
Phase: N/A
Study type: Observational

Pheochromocytoma or paraganglioma are tumors generating hypertension as a symptom. Different biological tests are currently available to diagnose these tumors. However, they all lack specificity since they do not distinguish cases of hypertension without pheochromocytoma or paraganglioma. To improve the diagnostic specificity of these tumors, the investigators are testing a new marker called EM66.

NCT ID: NCT01013155 Completed - Clinical trials for Essential Hypertension

Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions

Start date: May 2007
Phase: N/A
Study type: Interventional

The objective of this study was to prove the bioequivalence of Perindopril Erbumine 8 mg tablet under fed conditions

NCT ID: NCT01012687 Completed - Clinical trials for Essential Hypertension

Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions

Start date: April 2007
Phase: N/A
Study type: Interventional

The objective of this study was to prove the bioequivalence of Perindopril Erbumine 8 mg tablets under fasting conditions.

NCT ID: NCT01001572 Completed - Clinical trials for Essential Hypertension

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Start date: September 2009
Phase: Phase 3
Study type: Interventional

This study assessed the efficacy and safety of the valsartan/amlodipine 160/5 mg single-pill combination in patients with uncomplicated essential hypertension not adequately controlled (MSDBP ≥90 mmHg and <110 mmHg) on valsartan 160 mg alone.

NCT ID: NCT00996281 Completed - Clinical trials for Essential Hypertension

Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension

Start date: October 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and tolerability of azilsartan medoxomil plus chlorthalidone, once daily (QD), versus olmesartan medoxomil-hydrochlorothiazide in adults with essential hypertension.

NCT ID: NCT00991783 Completed - Clinical trials for Essential Hypertension

A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers

Start date: August 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of fimasartan on pharmacokinetics, and the safety of digoxin.

NCT ID: NCT00991705 Completed - Clinical trials for Essential Hypertension

A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Start date: July 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of atorvastatin on the pharmacokinetics of fimasartan.